Amedeo Smart

Free Medical Literature Service

 

Amedeo

Gastric Cancer
  Free Subscription

Articles published in
Cancer Res
    September 2025
  1. KIM J, Shrestha C, Lee G, Jung D, et al
    Condensation of the Golgi Apparatus Activates YAP1 to Promote Gastric Cancer Progression.
    Cancer Res. 2025 Sep 8. doi: 10.1158/0008-5472.CAN-24-3920.
    >> Share

    August 2025
  2. CONTICELLI D, Volante M, Pietrantonio F, Orru C, et al
    AREG and EREG Are Predictive Biomarkers of Response to EGFR Inhibition in Gastroesophageal Cancer.
    Cancer Res. 2025;85:3111-3122.
    >> Share

    May 2025
  3. XU X, Yan C, Bian L, Li Z, et al
    Genomic Analyses Reveal the Evolving Characteristics of Intestinal Metaplasia and Gastric Cancer.
    Cancer Res. 2025 May 16. doi: 10.1158/0008-5472.CAN-24-4065.
    >> Share

  4. KUAI X, Li L, Chen R, Wang K, et al
    Correction: SCFFBXW7/GSK3beta-Mediated GFI1 Degradation Suppresses Proliferation of Gastric Cancer Cells.
    Cancer Res. 2025;85:1739.
    >> Share

    April 2025
  5. QIU B, Zheng Y, Liu S, Song R, et al
    Multi-task Deep Learning Based on Longitudinal CT Images Facilitates Prediction of Lymph Node Metastasis and Survival in Chemotherapy-Treated Gastric Cancer.
    Cancer Res. 2025 Apr 30. doi: 10.1158/0008-5472.CAN-24-4190.
    >> Share

    March 2025
  6. LIN GT, Yan C, Li LJ, Qiu XW, et al
    Combining Apatinib and Oxaliplatin Remodels the Immunosuppressive Tumor Microenvironment and Sensitizes Desert-Type Gastric Cancer to Immunotherapy.
    Cancer Res. 2025 Mar 7. doi: 10.1158/0008-5472.CAN-24-2697.
    >> Share

    February 2025
  7. ZHANG T, Li Y, Zhai E, Zhao R, et al
    Intratumoral Fusobacterium nucleatum Recruits Tumor-Associated Neutrophils to Promote Gastric Cancer Progression and Immune Evasion.
    Cancer Res. 2025 Feb 24. doi: 10.1158/0008-5472.CAN-24-2580.
    >> Share

    October 2024
  8. CUI Y, Chang Y, Ma X, Sun M, et al
    Ephrin A1 Stimulates CCL2 Secretion to Facilitate Pre-metastatic Niche Formation and Promote Gastric Cancer Liver Metastasis.
    Cancer Res. 2024 Oct 16. doi: 10.1158/0008-5472.CAN-24-1254.
    >> Share

    July 2024
  9. LIU X, Chen B, Xie F, Wong KY, et al
    FOXP4 is a Direct YAP1 Target that Promotes Gastric Cancer Stemness and Drives Metastasis.
    Cancer Res. 2024 Jul 24. doi: 10.1158/0008-5472.CAN-23-3074.
    >> Share

  10. LIU S, Lin C, Lin X, Lin P, et al
    NAT10 Phase Separation Regulates YTHDF1 Splicing to Promote Gastric Cancer Progression.
    Cancer Res. 2024 Jul 18. doi: 10.1158/0008-5472.CAN-23-4062.
    >> Share

  11. GNANAPRAGASAM A, Kirbizakis E, Li A, White KH, et al
    HiChIP-Based Epigenomic Footprinting Identifies a Promoter Variant of UXS1 That Confers Genetic Susceptibility to Gastroesophageal Cancer.
    Cancer Res. 2024;84:2377-2389.
    >> Share

    December 2023
  12. TU RH, Wu SZ, Huang ZN, Zhong Q, et al
    Neurotransmitter Receptor HTR2B Regulates Lipid Metabolism to Inhibit Ferroptosis in Gastric Cancer.
    Cancer Res. 2023;83:3868-3885.
    >> Share

    September 2023
  13. FAN Y, Song S, Li Y, Dhar SS, et al
    Galectin-3 Cooperates with CD47 to Suppress Phagocytosis and T cell Immunity in Gastric Cancer Peritoneal Metastases.
    Cancer Res. 2023 Sep 22. doi: 10.1158/0008-5472.CAN-23-0783.
    >> Share

    August 2023
  14. YE H, Shi W, Yang J, Wang L, et al
    PICH activates Cyclin A1 transcription to drive S-phase progression and chemoresistance in gastric cancer.
    Cancer Res. 2023 Aug 30. doi: 10.1158/0008-5472.CAN-23-1331.
    >> Share

    May 2023
  15. PETRELLI A, Rizzolio S, Pietrantonio F, Bellomo SE, et al
    BRCA2 Germline Mutations Identify Gastric Cancers Responsive to PARP Inhibitors.
    Cancer Res. 2023 May 2:OF1-OF12. doi: 10.1158/0008-5472.CAN-22-2620.
    >> Share

    March 2023
  16. NARGUND AM, Xu C, Mandoli A, Okabe A, et al
    Correction: Chromatin Rewiring by Mismatch Repair Protein MSH2 Alters Cell Adhesion Pathways and Sensitivity to BET Inhibition in Gastric Cancer.
    Cancer Res. 2023;83:804.
    >> Share

  17. TAURIELLO DVF
    Targeting CAFs to Improve Anti-PD-1 Checkpoint Immunotherapy.
    Cancer Res. 2023;83:655-656.
    >> Share

  18. AKIYAMA T, Yasuda T, Uchihara T, Yasuda-Yoshihara N, et al
    Stromal Reprogramming through Dual PDGFRalpha/beta Blockade Boosts the Efficacy of Anti-PD-1 Immunotherapy in Fibrotic Tumors.
    Cancer Res. 2023;83:753-770.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016